Bedaquiline (trade name Sirturo code names TMC207 and R207910) is a diarylquinoline anti-tuberculosis drug which was discovered by a team led by Koen Andries at Janssen Pharmaceutica. When it was approved by the FDA on the 28th December 2012 it was the first new medicine to fight TB in more than forty years and is specifically approved to treat multi-drug-resistant tuberculosis.
This page contains content from the copyrighted Wikipedia article "Bedaquiline"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
